Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S studyHenriette Farkas, William Sheridan, Jonny Peter et al.|Clinical and Translational Allergy|2021Cited by 54
Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized TrialSorena Kiani‐Alikhan, William R. Lumry|The Journal of Allergy and Clinical Immunology In Practice|2023Cited by 25